{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:13:53Z","timestamp":1783689233759,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00280-017-3243-7","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T04:41:57Z","timestamp":1485924117000},"page":"519-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II\/III rectal cancer: the FACT trial"],"prefix":"10.1007","volume":"79","author":[{"given":"Junichi","family":"Koike","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimihiko","family":"Funahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yoshimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Saida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Ochiai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Shiokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimpei","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Itabashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kameoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"key":"3243_CR1","unstructured":"Cancer Registry and Statistics. Cancer Information Service, National Cancer Center, Japan"},{"key":"3243_CR2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1470-2045(09)70330-4","volume":"11","author":"G Folprecht","year":"2010","unstructured":"Folprecht G, Gruenberger T, Bechstein WO et al (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11:38\u201347","journal-title":"Lancet Oncol"},{"key":"3243_CR3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10147-012-0382-z","volume":"18","author":"T Takahashi","year":"2013","unstructured":"Takahashi T, Shibata Y, Tojima Y et al (2013) Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study. Int J Clin Oncol 18:335\u2013342","journal-title":"Int J Clin Oncol"},{"key":"3243_CR4","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00280-014-2417-9","volume":"73","author":"J Hasegawa","year":"2014","unstructured":"Hasegawa J, Nishimura J, Mizushima T et al (2014) Neoadjuvant capecitabine and oxaliplatin (XELOX) combined with bevacizumab for high-risk localized rectal cancer. Cancer Chemother Pharmacol 73:1079\u20131087","journal-title":"Cancer Chemother Pharmacol"},{"key":"3243_CR5","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/jjco\/hyt115","volume":"43","author":"K Uehara","year":"2013","unstructured":"Uehara K, Hiramatsu K, Maeda A et al (2013) Neoadjuvant oxaliplatin and capecitabine and bevacizumab without radiotherapy for poor-risk rectal cancer: N-SOG 03 Phase II trial. Jpn J Clin Oncol 43:964\u2013971","journal-title":"Jpn J Clin Oncol"},{"key":"3243_CR6","doi-asserted-by":"crossref","first-page":"318","DOI":"10.5858\/2006-130-318-KIIRCC","volume":"130","author":"CC Compton","year":"2006","unstructured":"Compton CC (2006) Key issues in reporting common cancer specimens: problems in pathologic staging of colon cancer. Arch Pathol Lab Med 130:318\u2013324","journal-title":"Arch Pathol Lab Med"},{"key":"3243_CR7","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","volume":"351","author":"R Sauer","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Eng J Med 351:1731\u20131740","journal-title":"N Eng J Med"},{"key":"3243_CR8","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.2011.40.1836","volume":"30","author":"R Sauer","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926\u20131933","journal-title":"J Clin Oncol"},{"key":"3243_CR9","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","volume":"93","author":"K Bujko","year":"2006","unstructured":"Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryj M (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215\u20131223","journal-title":"Br J Surg"},{"key":"3243_CR10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1463-1318.2011.02815.x","volume":"14","author":"T Latkauskas","year":"2012","unstructured":"Latkauskas T, Pauzas H, Gineikiene I et al (2012) Initial results of randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal Dis 14:294\u2013298","journal-title":"Colorectal Dis"},{"key":"3243_CR11","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","volume":"24","author":"JP G\u00e9rard","year":"2006","unstructured":"G\u00e9rard JP, Conroy T, Bonnetain F et al (2006) Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620\u20134625","journal-title":"J Clin Oncol"},{"key":"3243_CR12","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","volume":"355","author":"JF Bosset","year":"2006","unstructured":"Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Eng J Med 355:1114\u20131123","journal-title":"N Eng J Med"},{"key":"3243_CR13","doi-asserted-by":"crossref","unstructured":"Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Eng J Med 336:980\u2013987","DOI":"10.1056\/NEJM199704033361402"},{"key":"3243_CR14","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","volume":"345","author":"E Kapiteijn","year":"2001","unstructured":"Kapiteijn E, Marijnen CA, Nagtegaal ID et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Eng J Med 345:638\u2013646","journal-title":"N Eng J Med"},{"key":"3243_CR15","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","volume":"12","author":"W Gijn van","year":"2011","unstructured":"van Gijn W, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomized controlled TME trial. Lancet Oncol 12:575\u2013582","journal-title":"Lancet Oncol"},{"key":"3243_CR16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2005.04.4875","volume":"24","author":"I Chau","year":"2006","unstructured":"Chau I, Brown G, Cunningham D et al (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668\u2013674","journal-title":"J Clin Oncol"},{"key":"3243_CR17","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1200\/JCO.2009.25.8541","volume":"28","author":"C Fern\u00e1ndez-Martos","year":"2010","unstructured":"Fern\u00e1ndez-Martos C, Pericay C, Aparicio J et al (2010) Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Group cancer de recto 3 study. J Clin Oncol 28:859\u2013865","journal-title":"J Clin Oncol"},{"key":"3243_CR18","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1200\/JCO.2004.08.173","volume":"22","author":"LL Gunderson","year":"2004","unstructured":"Gunderson LL, Sargent DJ, Tepper JE et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22:1785\u20131796","journal-title":"J Clin Oncol"},{"key":"3243_CR19","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1200\/JCO.2013.51.7904","volume":"32","author":"D Schrag","year":"2014","unstructured":"Schrag D, Weiser MR, Goodman KA et al (2014) Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial. J Clin Oncol 32:513\u2013518","journal-title":"J Clin Oncol"},{"key":"3243_CR20","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2217\/fon.14.127","volume":"10","author":"F Sclafani","year":"2014","unstructured":"Sclafani F, Cunningham D (2014) Neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer. Future Oncol 10:2243\u20132257","journal-title":"Future Oncol"},{"key":"3243_CR21","unstructured":"Neoadjuvant FOLFOX6 chemotherapy with or without radiation in rectal cancer (FOWARC). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01211210 (2010). Accessed 16 Jun 2015"},{"key":"3243_CR22","doi-asserted-by":"crossref","first-page":"5s","DOI":"10.1200\/jco.2014.32.30_suppl.101","volume":"32","author":"M Harrison","year":"2014","unstructured":"Harrison M, Beare S, Bridgewater, JA et al (2014) Bevacizumab and combination chemotherapy in rectal cancer until surgery (BACCHUS): a phase II, multicenter, open-label, randomized study of neoadjuvant chemotherapy alone without radiation in patients with MRI-defined high-risk cancer of the rectum not threatening the circumferential margin. J Clin Oncol 32:5s (suppl; abstr TPS3653)","journal-title":"J Clin Oncol"},{"key":"3243_CR23","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1200\/JCO.2005.07.740","volume":"23","author":"SR Alberts","year":"2005","unstructured":"Alberts SR, Horvath WL, Sternfeld WC et al (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23:9243\u20139249","journal-title":"J Clin Oncol"},{"key":"3243_CR24","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1200\/JCO.2008.20.6771","volume":"27","author":"T Andr\u00e9","year":"2009","unstructured":"Andr\u00e9 T, Boni C, Navarro M et al (2009) Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 27:3109\u20133116","journal-title":"J Clin Oncol"},{"key":"3243_CR25","doi-asserted-by":"crossref","unstructured":"Kotaka M, Yoshino T, Oba K, et al (2015) Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial). Cancer Chemother Pharmacol [Epub ahead of print]","DOI":"10.1007\/s00280-015-2757-0"},{"key":"3243_CR26","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","volume":"51","author":"C Tournigand","year":"2004","unstructured":"Tournigand C, Andr\u00e9 T, Achille E et al (2004) FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 51:229\u2013237","journal-title":"J Clin Oncol"},{"key":"3243_CR27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0360-3016(02)02764-5","volume":"53","author":"V Valentini","year":"2002","unstructured":"Valentini V, Coco C, Picciocchi A et al (2002) Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 53:664\u2013674","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3243_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-8140(99)00054-7","volume":"51","author":"NA Janjan","year":"1999","unstructured":"Janjan NA, Abbruzzese J, Pazdur R et al (1999) Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer. Radiother Oncol 51:153\u2013160","journal-title":"Radiother Oncol"},{"key":"3243_CR29","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1245\/s10434-007-9471-z","volume":"14","author":"LJ Kuo","year":"2007","unstructured":"Kuo LJ, Liu MC, Jian JJ et al (2007) Is final TNM staging a predictor for survival in locally advanced rectal cancer after preoperative chemoradiation therapy? Ann Surg Oncol 14:2766\u20132772","journal-title":"Ann Surg Oncol"},{"key":"3243_CR30","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejso.2016.02.014","volume":"42","author":"T Kamiya","year":"2016","unstructured":"Kamiya T, Uehara K, Nakayama G et al (2016) Early results of multicenter phase II trial of perioperative oxaliplatin and capecitabine without radiotherapy for high-risk rectal cancer: CORONA I study. Eur J Surg Oncol 42:829\u2013835","journal-title":"Eur J Surg Oncol"},{"key":"3243_CR31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.bjc.6602330","volume":"92","author":"SC Glasgow","year":"2005","unstructured":"Glasgow SC, Yu J, Carvalho LP et al (2005) Unfavourable expression of pharmacologic markers in mucinous colorectal cancer. Br J Cancer 92:259\u2013264","journal-title":"Br J Cancer"},{"key":"3243_CR32","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnci\/djr153","volume":"103","author":"FA Sinicrope","year":"2011","unstructured":"Sinicrope FA, Foster NR, Thibodeau SN et al (2011) DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy. J Natl Cancer Inst 103:863\u2013875","journal-title":"J Natl Cancer Inst"},{"key":"3243_CR33","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ et al (2003) Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Eng J Med 349:247\u2013257","journal-title":"N Eng J Med"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-017-3243-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-017-3243-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,23]],"date-time":"2022-07-23T04:10:45Z","timestamp":1658549445000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-017-3243-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1007\/s00280-017-3243-7","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}